These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 13892290)
21. Potentiation of the mydriatic effect of norepinephrine in the rabbit after monoamine oxidase inhibition. Colasanti BK; Bárány EH Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):200-3. PubMed ID: 33123 [TBL] [Abstract][Full Text] [Related]
22. The effects of pheniprazine on visual imagery in perceptual deprivation. Marjerrison G J Nerv Ment Dis; 1966 Mar; 142(3):254-64. PubMed ID: 4379955 [No Abstract] [Full Text] [Related]
23. The hepatic injury of monoamine oxidase inhibitors. Zimmerman HJ; Ishak KG J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504 [No Abstract] [Full Text] [Related]
24. ON THE GANGLIONIC ACTIONS OF CERTAIN ANTI-DEPRESSANT DRUGS. URQUIAGA X; VILLARREAL J; ALONSO-DEFLORIDA F; PARDO EG Arch Int Pharmacodyn Ther; 1963 Nov; 146():126-33. PubMed ID: 14077702 [No Abstract] [Full Text] [Related]
25. Stupor from dextroamphetamineamobarbital and monoamine oxidase inhibitor, phenelzine. ROECKER RD; LANE M J Med Soc N J; 1961 Feb; 58():47-9. PubMed ID: 13742660 [No Abstract] [Full Text] [Related]
26. Enzyme shock. ANTON AT Ohio State Med J; 1962 Aug; 58():912-4. PubMed ID: 13861786 [No Abstract] [Full Text] [Related]
27. EVIDENCE FOR A FALSE NEUROCHEMICAL TRANSMITTER AS A MECHANISM FOR THE HYPOTENSIVE EFFECT OF MONOAMINE OXIDASE INHIBITORS. KOPIN IJ; FISCHER JE; MUSACCHIO J; HORST WD Proc Natl Acad Sci U S A; 1964 Sep; 52(3):716-21. PubMed ID: 14212547 [No Abstract] [Full Text] [Related]
30. [ANTI-FIBRILLATION PROPERTIES OF SOME HYDRAZINE DERIVATIVES]. POPOVA NK; ILIUCHENOK RIu; SERGIEVSKII VS Farmakol Toksikol; 1964; 27():454-7. PubMed ID: 14188541 [No Abstract] [Full Text] [Related]
31. Amine metabolism after an overdose of a monoamine oxidase inhibitor. BALDRIDGE ET; MILLER LV; HAVERBACK BJ; BRUNJES S N Engl J Med; 1962 Aug; 267():421-6. PubMed ID: 13864324 [No Abstract] [Full Text] [Related]
32. [A complication in combined use of a phenothiazine derivative and a monoamine oxidase inhibitor]. DEGKWITZ R; NESSWETHA L Nervenarzt; 1962 Mar; 33():138-9. PubMed ID: 13884859 [No Abstract] [Full Text] [Related]
33. [Synthesis of 3,4-(methylenedioxy)-benzoic acid hydrazides and their antimonoaminoxidasic activity]. Mazzone G; Arrigo Reina R Boll Chim Farm; 1973 Jan; 112(1):35-44. PubMed ID: 4710260 [No Abstract] [Full Text] [Related]
34. "FALSE NEUROCHEMICAL TRANSMITTERS" AND THE MECHANISM OF SYMPATHETIC BLOCKADE BY MONOAMINE OXIDASE INHIBITORS. KOPIN IJ; FISCHER JE; MUSACCHIO JM; HORST WD; WEISE VK J Pharmacol Exp Ther; 1965 Feb; 147():186-93. PubMed ID: 14259496 [No Abstract] [Full Text] [Related]
35. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects]. LEVY J Actual Pharmacol (Paris); 1961; 14():125-73. PubMed ID: 14464772 [No Abstract] [Full Text] [Related]
36. [ACTION OF SULFONAMIDOPHENYLHYDRAZINES ON MONOAMINE OXIDASE AND DIAMINOXIDASE]. LESPAGNOL A; BAR D; OSTEUX R; ROBELET A; MIZON-CAPRON C Ann Pharm Fr; 1964; 22():417-28. PubMed ID: 14191784 [No Abstract] [Full Text] [Related]
37. DRUG AND VIRAL JAUNDICE. WEST ED Br Med J; 1964 Aug; 2(5406):445. PubMed ID: 14160252 [No Abstract] [Full Text] [Related]
38. CHEMICAL REMEDIES FOR DEPRESSION. AYD FJ Med Sci; 1964 Sep; 15():37-44. PubMed ID: 14174082 [No Abstract] [Full Text] [Related]